Evidence map›Paper›PMID 23653679›Full record

ArticlePloS one2013

Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice.

Igor Branchi, Sara Santarelli, Sara Capoccia, Silvia Poggini, Ivana D'Andrea, Francesca Cirulli, Enrico Alleva

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06306209 (Inflammatory Control of Antidepressant Efficacy), which is not on this map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06306209 unknown statusnot on this mapstarted 2021, after this paper: background citation

Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach

TypeobservationalSponsorIRCCS San RaffaeleRan2021 to 2025Enrolled80ConditionsMood Disorders, Major Depressive DisorderArmsTreatment as usual (TAU), i.e., pharmacotherapy plus clinical management
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Igor BranchiDepartment of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy. branchi@iss.it
Sara Santarelli
Sara Capoccia
Silvia Poggini
Ivana D'Andrea
Francesca Cirulli
Enrico Alleva
Istituto Superiore di Sanità · ITIstituto Neurologico Mediterraneo · ITUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antidepressants represent the standard treatment for major depression. However, their efficacy is variable and incomplete. A growing number of studies suggest that the environment plays a major role in determining the efficacy of these drugs, specifically of selective serotonin reuptake inhibitors (SSRI). A recent hypothesis posits that the increase in serotonin levels induced by SSRI may not affect mood per se, but enhances neural plasticity and, consequently, renders the individual more susceptible to the influence of the environment. Thus, SSRI administration in a favorable environment would lead to a reduction of symptoms, while in a stressful environment might lead to a worse prognosis. To test this hypothesis, we treated C57BL/6 adult male mice with chronic fluoxetine while exposing them to either (i) an enriched environment, after exposure to a chronic stress period aimed at inducing a depression-like phenotype, or (ii) a stressful environment. Anhedonia, brain BDNF and circulating corticosterone levels, considered endophenotypes of depression, were investigated. Mice treated with fluoxetine in an enriched condition improved their depression-like phenotype compared to controls, displaying higher saccharin preference, higher brain BDNF levels and reduced corticosterone levels. By contrast, when chronic fluoxetine administration occurred in a stressful condition, mice showed a more distinct worsening of the depression-like profile, displaying a faster decrease of saccharin preference, lower brain BDNF levels and increased corticosterone levels. Our findings suggest that the effect of SSRI on depression-like phenotypes in mice is not determined by the drug per se but is induced by the drug and driven by the environment. These findings may be helpful to explain variable effects of SSRI found in clinical practice and to device strategies aimed at enhancing their efficacy by means of controlling environmental conditions.

Indexed as

Stress, PsychologicalAnhedoniaAnimalsAntidepressive AgentsBehavior, AnimalBrainBrain-Derived Neurotrophic FactorCorticosteroneDrug Evaluation, PreclinicalEnvironmentFluoxetineMajor Depressive DisorderMaleMiceMice, Inbred C57BLSelective Serotonin Reuptake InhibitorsAntidepressive AgentsBrain-Derived Neurotrophic FactorCorticosteroneFluoxetineSelective Serotonin Reuptake InhibitorsSerotonin

Identifiers

PMID23653679
PMCPMC3639948
OpenAlexW2074465939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.